Harvard Bioscience, Inc. (NASDAQ:HBIO)

CAPS Rating: 4 out of 5

A developer, manufacturer and marketer of a range of specialized products, primarily apparatus and scientific instruments, used to improve life science research at pharmaceutical & biotechnology companies, universities & government laboratories worldwide.

Recs

0
Player Avatar GirlsUnder30 (98.22) Submitted: 1/29/2013 8:02:31 PM : Outperform Start Price: $3.56 HBIO Score: -17.40

Limited downside with good upside potential but definitely not for the faint of heart.

Featured Broker Partners


Advertisement